Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

Zinc is vital for immune health, growth, and preventing diarrhea.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.